Finance

Lists
4549:TYO
Eiken Chemical Co Ltd
JP¥ २,२७३.००
+१.४७%
(+३३.००) 1D
नोभेम्बर १८, १५:३०:०० GMT+९  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4549...
Open
JP¥ २,२४९
High
JP¥ २,२८५
Low
JP¥ २,२३१
Mkt. cap
७८.५१ अरब
Avg. vol.
१.२९ लाख
Volume
६२.०० हजार
Dividend
२.५५%
Quarterly dividend
JP¥ १४
Ex-dividend date
२०२६ सेप्टेम्बर २९
P/E ratio
४०.५२
52-wk high
JP¥ ३,५००
52-wk low
JP¥ २,०२१
EPS
JP¥ ५६
Shares outstanding
३.६९ करोड
No. of employees
६९६
Open
JP¥ २,२४९
High
JP¥ २,२८५
Low
JP¥ २,२३१
Mkt. cap
७८.५१ अरब
Avg. vol.
१.२९ लाख
Volume
६२.०० हजार
Dividend
२.५५%
Quarterly dividend
JP¥ १४
Ex-dividend date
२०२६ सेप्टेम्बर २९
P/E ratio
४०.५२
52-wk high
JP¥ ३,५००
52-wk low
JP¥ २,०२१
EPS
JP¥ ५६
Shares outstanding
३.६९ करोड
No. of employees
६९६
News stories
From web sources and news partners
TradingView
TradingView
·
१ घण्टा पहिले
S&P 500, Nasdaq find footing as Nvidia treads water
24/7 Wall St.
24/7 Wall St.
·
१६ मिनेट पहिले
S&P 500 Slides 0.6% at Midday as the Dow Drops Over 1%
ChartMill
ChartMill
·
१ घण्टा पहिले
S&P 500 Gap-Down Movers for Nov. 18 Session
Profile
Eiken Chemical is a Japanese company headquartered in Tokyo, established in 1939. The company's business is manufacturing and sales of clinical diagnostics and equipment. Eiken's major products include fecal immunochemical test reagents, immunological and serological reagents, microbiological reagents, urinalysis test strips, clinical chemistry reagents, molecular genetics, medical devices and industrial products. The company in 1998 developed the Loop-mediated isothermal amplification method, a nucleic acid amplification method, and an alternative to traditional PCR. Wikipedia
About Eiken Chemical Co Ltd
CEOMorifumi Wada
Employees६९६
Founded१९३९ फेब्रुअरी २०
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
१०.९५ अरब
१०.५२ अरब
१०.६९ अरब
१०.६६ अरब
Cost of goods sold
६.७० अरब
६.९७ अरब
६.६५ अरब
६.६५ अरब
Cost of revenue
६.७० अरब
६.९७ अरब
६.६५ अरब
६.६५ अरब
Research and development expenses
-
३.६८ अरब
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३.२० अरब
-२६.२० करोड
३.२५ अरब
३.०९ अरब
Operating expense
३.२० अरब
३.४१ अरब
३.२५ अरब
३.०९ अरब
Total operating expenses
९.९० अरब
१०.३८ अरब
९.९० अरब
९.७४ अरब
Operating income
१.०५ अरब
१४.१० करोड
७९.४० करोड
९२.०० करोड
Other non operating income
-५.४० करोड
१.९० करोड
४.८० करोड
१०.०० करोड
EBT including unusual items
१.०० अरब
१०.२० करोड
८०.८५ करोड
९७.७० करोड
EBT excluding unusual items
९९.५० करोड
-१.८९ अरब
८०.८० करोड
९७.६० करोड
Income tax expense
२६.०० करोड
११.६० करोड
२४.६० करोड
२९.७० करोड
Effective tax rate
२५.९२%
११३.७३%
३०.४३%
३०.४०%
Other operating expenses
-
-
-
-
Net income
७४.३० करोड
-१.४० करोड
५६.२५ करोड
६८.०० करोड
Net profit margin
६.७९%
-०.१३%
५.२६%
६.३८%
Earnings per share
-
-
-
-
Interest and investment income
४०.०० लाख
५०.०० लाख
१.२० करोड
१.७० करोड
Interest expense
-५०.०० लाख
-१.५० करोड
-१.९५ करोड
-२.०० करोड
Net interest expenses
-१०.०० लाख
-१.०० करोड
-७५.०० लाख
-३०.०० लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
१.६२ अरब
७७.५० करोड
१.४३ अरब
१.५३ अरब
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू